RadNet, Inc.

https://www.radnet.com/

RadNet, Inc. is a national leader in providing outpatient diagnostic imaging services, headquartered in Los Angeles, California. The company's mission is to deliver accessible, high-quality, cost-effective, patient-centered outpatient diagnostic imaging services, leveraging advanced technology and clinical excellence to improve diagnostic accuracy and access to care.

RadNet operates in two primary segments: Imaging Centers and Digital Health. Its comprehensive services include Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Nuclear Medicine, Mammography (including 3D), Ultrasound, Diagnostic Radiology (X-ray), and Fluoroscopy. The Digital Health segment, primarily through its DeepHealth and eRAD subsidiaries, develops and deploys AI-powered health informatics solutions designed to enhance quality, efficiency, and outcomes in imaging and radiology workflows. As the largest operator of freestanding, fixed-site diagnostic imaging centers in the United States, RadNet owns and/or operates over 400 centers across multiple states, including Arizona, California, Delaware, Florida, Indiana, Maryland, New Jersey, New York, Texas, and Virginia.

Under the leadership of President and CEO Dr. Howard Berger, RadNet continues its strategic expansion and technological innovation. Recent notable developments include a joint venture with Saint Alphonsus Health System in Idaho in April 2026, which involved acquiring a controlling stake in Intermountain Medical Imaging, and an expansion into Indiana in February 2026. The company has also significantly invested in artificial intelligence, exemplified by the acquisition of Gleamer, integrated into DeepHealth, positioning RadNet as a major provider of radiology clinical AI solutions. RadNet reported record revenue and adjusted EBITDA in the fourth quarter of 2025, underscoring its strong market positioning and growth trajectory in the evolving healthcare landscape.

Latest updates

RadNet Acquires Idaho Imaging Centers in $30M Joint Venture

Event summary

  • RadNet is acquiring a majority equity position in Intermountain Medical Imaging, LLC, owner of five outpatient imaging centers in Boise, Idaho, for an undisclosed amount.
  • The joint venture with Saint Alphonsus Health System is projected to generate approximately $30 million in annual revenue for RadNet.
  • RadNet will assume management of the five imaging centers, which offer a range of diagnostic services including MRI, CT, and mammography.
  • DeepHealth’s AI-powered solutions will be integrated across the joint venture for clinical interpretation, reporting, and operational efficiency.

The big picture

This joint venture represents RadNet's continued strategy of expanding its geographic footprint and leveraging its DeepHealth subsidiary to modernize diagnostic imaging operations. The $30 million revenue projection suggests a significant investment in a regional market, signaling a broader trend of healthcare systems seeking to outsource specialized services and adopt AI-driven solutions to address workforce shortages and improve patient care. The deal also highlights the increasing importance of integrated technology platforms in the competitive landscape of outpatient imaging.

What we're watching

Integration Risk
The success of the venture hinges on RadNet’s ability to effectively integrate the five imaging centers and DeepHealth’s technology into existing workflows, which could face operational and cultural challenges.
AI Adoption
The pace at which Gem State Radiology and Saint Alphonsus Health System adopt and utilize DeepHealth’s AI solutions will determine the realized efficiency gains and impact on radiologist productivity.
Competitive Landscape
How RadNet’s expansion into Idaho impacts existing diagnostic imaging providers and influences pricing strategies within the regional market warrants close observation.

RadNet CFO to Address KeyBanc Healthcare Forum Amidst Imaging Sector Consolidation

Event summary

  • RadNet CFO Mark Stolper will present at the KeyBanc Capital Markets Healthcare Forum on March 17, 2026.
  • The presentation will be webcast live and archived at the provided URL.
  • RadNet operates over 11,000 team members across 10 states.
  • The company is a leading provider of diagnostic imaging services with a network of owned and operated outpatient imaging centers.

The big picture

RadNet's participation in the KeyBanc forum signals a continued effort to engage with investors and communicate its strategic direction. The diagnostic imaging sector has seen increased consolidation in recent years, putting pressure on independent providers like RadNet to demonstrate value and efficiency. Stolper's remarks will be closely watched for insights into RadNet's response to these competitive pressures and its plans for future growth.

What we're watching

Financial Scrutiny
Given RadNet's past financial challenges, Stolper's presentation will likely be heavily scrutinized for signs of improved profitability and debt management.
Market Positioning
The presentation will reveal how RadNet intends to compete within a consolidating diagnostic imaging market, particularly against larger, more diversified players.
DeepHealth Adoption
The pace at which RadNet integrates and monetizes its DeepHealth AI solutions will be a key indicator of its ability to innovate and differentiate its services.

RadNet CFO to Address Barclays Healthcare Conference Amidst Imaging Sector Consolidation

Event summary

  • RadNet CFO Mark Stolper will present at the Barclays Global Healthcare Conference on March 12, 2026.
  • The presentation will be webcast live and archived at the provided URL.
  • RadNet operates over 11,000 team members across 10 states.
  • The company is a leading provider of diagnostic imaging services with a network of owned and operated outpatient imaging centers.

The big picture

RadNet's participation in the Barclays conference highlights the ongoing investor interest in the diagnostic imaging sector, which is experiencing consolidation and disruption from technological advancements. The company's size ($2.2B market cap) makes it a significant player, and its CFO’s presentation will be closely watched for insights into its strategic direction and financial outlook. The broader healthcare landscape is facing pricing pressures and increased scrutiny of operational efficiency, which will likely be key themes in the discussion.

What we're watching

Financial Scrutiny
Investor attention will likely focus on RadNet’s profitability given the ongoing pressure on healthcare reimbursements and the potential impact of AI-driven diagnostics on service pricing.
Market Positioning
The presentation will reveal the extent to which RadNet’s DeepHealth brand is gaining traction and contributing to revenue diversification beyond core imaging services.
Operational Efficiency
The conference provides an opportunity to assess whether RadNet can sustain its scale and maintain operational efficiency amidst increasing competition and rising labor costs.

DeepHealth Bolsters AI Portfolio with Gleamer Acquisition, Targets European Screening Expansion

Event summary

  • DeepHealth, a RadNet subsidiary, unveiled a comprehensive suite of native clinical AI solutions at ECR 2026, spanning MR, CT, X-ray, Mammography, and Ultrasound.
  • The company acquired Gleamer to expand its capabilities in screening tools and acute diagnostic care, particularly in musculoskeletal and X-ray imaging.
  • DeepHealth’s Breast Suite, validated by a Nature Health study showing a 21% increase in breast cancer detection, now includes AI-powered breast ultrasound and risk assessment.
  • DeepHealth’s AI Studio platform integrates over 140 AI algorithms from 75 partners, offering governance and workflow orchestration.

The big picture

DeepHealth’s expansion, fueled by acquisitions and a focus on population health screening, reflects the broader trend of AI transforming radiology and healthcare delivery. RadNet’s investment in DeepHealth signals a commitment to digital health solutions, aiming to address rising healthcare costs and workforce shortages through automation and improved diagnostic accuracy. The company’s focus on European markets highlights the growing demand for AI-powered solutions in regions facing demographic shifts and strained healthcare resources.

What we're watching

Regulatory Approval
The speed of CE marking and potential FDA clearance for DeepHealth’s expanded suite will dictate its ability to penetrate the US market and realize the stated benefits.
Integration Risk
Successfully integrating Gleamer’s technology and team into DeepHealth’s existing platform will be critical to realizing the promised synergies and avoiding operational disruption.
Market Adoption
The ability of DeepHealth to convince healthcare systems to adopt AI-driven workflows, particularly in regions with differing regulatory landscapes and clinician acceptance, will determine the long-term success of the strategy.

RadNet to Detail AI Imaging Acquisition, Digital Health Strategy

Event summary

  • RadNet acquired Gleamer SAS, a French AI-powered medical imaging solutions provider, in an undisclosed deal.
  • RadNet will host a conference call and presentation on March 5, 2026, at 7:30 AM Pacific Time to discuss the acquisition and its digital health strategy.
  • Gleamer’s solutions support radiologists and clinicians across X-ray, Mammography, CT, and MRI, with over 30 million exams analyzed across 2,250 locations.
  • DeepHealth, RadNet’s digital health subsidiary, focuses on AI-powered health informatics and operates a cloud-first platform (DeepHealth OS).

The big picture

RadNet’s acquisition of Gleamer signals a continued push by diagnostic imaging providers to incorporate AI and digital health solutions to address rising demand and improve efficiency. The deal underscores the growing importance of AI in radiology, as companies seek to automate tasks, improve diagnostic accuracy, and personalize patient care. Gleamer's global reach and established peer-reviewed publications suggest RadNet is aiming to expand its digital health footprint beyond its existing US markets.

What we're watching

Integration Risk
The success of the acquisition hinges on RadNet’s ability to effectively integrate Gleamer’s technology and team, which could be complicated by cultural differences and differing operational approaches.
Market Adoption
The pace at which RadNet can deploy Gleamer’s solutions across its network and attract new customers will determine the acquisition’s financial impact.
Competitive Landscape
How RadNet leverages Gleamer's technology to differentiate its DeepHealth offerings against competitors in the increasingly crowded AI-powered medical imaging space will be crucial for sustained growth.

RadNet CFO to Address Investors Amidst Imaging Sector Consolidation

Event summary

  • RadNet CFO Mark Stolper will present at the Raymond James Institutional Investors Conference on March 3, 2026.
  • The presentation will be webcast live and available for replay.
  • The conference is being held in Orlando, Florida at the JW Marriott Grande Lakes.
  • RadNet operates over 11,000 team members across multiple states including Arizona, California, and Texas.

The big picture

RadNet's presentation at Raymond James comes amidst a period of consolidation within the diagnostic imaging industry, with larger players acquiring smaller practices to gain scale and negotiating power. The company's ability to demonstrate sustainable growth and profitability will be critical for maintaining investor confidence. The presentation offers a window into RadNet's strategy for competing in a challenging environment, particularly given its significant employee base and geographic footprint.

What we're watching

Financial Scrutiny
Investor attention will likely focus on RadNet's profitability given the ongoing pressure on diagnostic imaging pricing and reimbursement rates.
Market Dynamics
The presentation will reveal how RadNet is navigating the increased consolidation within the diagnostic imaging sector, and whether its DeepHealth AI solutions are contributing meaningfully to revenue.
Operational Efficiency
The pace at which RadNet can optimize its network of imaging centers and reduce operating expenses will be a key indicator of its long-term competitiveness.

RadNet Revenue Surges, Digital Health Segment Shows Mixed Results

Event summary

  • RadNet reported record Q4 2025 revenue of $547.7 million, a 14.8% increase year-over-year.
  • The Digital Health segment revenue grew 48.2% to $27.9 million, but Adjusted EBITDA only increased 8.9% to $4.9 million.
  • RadNet's aggregate advanced imaging procedural volumes increased 14.1%, with same-center growth at 9.6%.
  • The company released 2026 guidance projecting Imaging Center revenue growth of 17%-19% and Digital Health revenue growth of 46%-56%.

The big picture

RadNet's strong revenue growth demonstrates the continued demand for diagnostic imaging services, but the Digital Health segment's profitability remains a key area of focus. The acquisition of Gleamer signals a significant bet on AI-powered solutions, aiming to transform the diagnostic imaging industry and address challenges like labor shortages. However, the company's ability to integrate these acquisitions and achieve its aggressive growth targets will be critical for long-term success.

What we're watching

Digital Health Profitability
Whether RadNet can improve the profitability of its Digital Health segment, given the acquisition of Gleamer and continued investments, will be crucial for overall financial performance.
Labor Cost Pressures
The company's guidance acknowledges headwinds from rising labor costs; the ability to offset these through automation and efficiency gains will be a key determinant of success.
Guidance Execution
The ambitious 2026 guidance, particularly for Digital Health, requires flawless execution across sales, marketing, and implementation, and may be vulnerable to competitive pressures.

RadNet Acquires Gleamer, Bolstering AI Leadership in Radiology

Event summary

  • RadNet acquired Gleamer SAS, a Paris-based radiology AI company, for up to €230 million.
  • Gleamer achieved an Annual Recurring Revenue (ARR) compound annual growth rate exceeding 90% from 2022 through 2025, expected to reach approximately $30 million ARR in 2026.
  • The acquisition integrates Gleamer into RadNet’s DeepHealth subsidiary, positioning it as the largest provider of radiology clinical AI solutions globally.
  • DeepHealth, combined with Gleamer, now supports 26 FDA-cleared and 22 CE-marked devices supporting 75+ indications.

The big picture

The acquisition underscores the growing importance of AI in radiology, driven by radiologist shortages and increasing imaging volumes. RadNet’s move to acquire Gleamer, a fast-growing European player, signals a strategic shift towards consolidating leadership in the clinical AI space, a market poised for significant expansion as healthcare providers seek to automate workflows and improve patient outcomes. The €230 million valuation reflects the high demand for AI solutions in radiology and the potential for substantial recurring revenue.

What we're watching

Integration Risk
The success of this acquisition hinges on RadNet’s ability to effectively integrate Gleamer’s operations and technology into DeepHealth, particularly given the cultural differences between a US-based and a European company.
Market Adoption
The pace at which RadNet can deploy Gleamer’s solutions across its network and achieve the promised cost efficiencies and productivity gains will determine the acquisition’s ROI.
Competitive Landscape
How DeepHealth will navigate the increasingly competitive landscape of radiology AI, especially with larger players potentially entering the market, will be crucial for sustaining its leadership position.

DeepHealth Secures CE Mark, AWS Deployment to Expand Remote Imaging Reach

Event summary

  • DeepHealth, a RadNet subsidiary, received CE Mark certification for its TechLive remote imaging solution, enabling commercialization in Europe.
  • TechLive is now available on AWS Marketplace, streamlining deployment and access globally.
  • TechLive has demonstrated a 42% reduction in MR room closures and a 27% increase in access to complex procedures within RadNet’s New York facilities.
  • The solution supports multiple imaging modalities (MR, CT, PET/CT, ultrasound) and is vendor-agnostic.

The big picture

DeepHealth’s TechLive addresses a critical need in European healthcare: mitigating workforce shortages and expanding access to advanced imaging. The CE Mark and AWS Marketplace listing represent a significant step towards international expansion, but success hinges on navigating complex regulatory landscapes and demonstrating clear ROI for healthcare providers. RadNet’s internal adoption and willingness to scale the solution will be a key indicator of DeepHealth’s long-term viability.

What we're watching

Market Adoption
The pace at which European healthcare providers adopt TechLive will depend on reimbursement models and existing IT infrastructure, potentially limiting initial growth.
Competitive Landscape
How DeepHealth differentiates TechLive from emerging competitors in the remote radiology space will be crucial for sustained market share, particularly given the solution’s reliance on existing infrastructure.
RadNet Integration
The extent to which RadNet leverages TechLive across its broader network, beyond the pilot programs, will determine the solution’s overall financial impact and influence DeepHealth’s future development.

RadNet Expands Midwest Footprint with $18M Northwest Radiology Acquisition

Event summary

  • RadNet has acquired Northwest Radiology Network, P.C., marking its entry into the Indiana market.
  • The acquisition includes six outpatient imaging centers in the Indianapolis area, primarily in Carmel.
  • Northwest Radiology's 18 radiologists will continue providing contracted services at the acquired locations.
  • The deal is projected to add approximately $18 million in annualized revenue to RadNet.
  • RadNet is aiming to shift Indiana’s healthcare from reactive detection toward proactive prevention.

The big picture

RadNet's acquisition of Northwest Radiology represents a strategic move to expand its geographic reach into the Midwest, a region with a growing population and increasing demand for outpatient diagnostic imaging services. The $18 million deal, while relatively small for a company of RadNet’s size, signals a continued focus on targeted acquisitions to bolster its market share and leverage its digital health solutions. This expansion also aligns with the broader trend of healthcare providers seeking to incorporate AI and advanced technologies to improve patient outcomes and operational efficiency.

What we're watching

Integration Risk
The success of the acquisition hinges on RadNet's ability to effectively integrate Northwest Radiology's operations and technology without disrupting existing patient care workflows.
Market Dynamics
Carmel’s rapid growth and ranking as a top Midwest city will be a key factor in determining the acquisition’s long-term profitability and RadNet’s ability to expand its presence in the region.
AI Adoption
The pace at which Northwest Radiology’s physicians adopt and utilize RadNet’s AI-powered technologies will influence the realization of anticipated benefits and the overall success of the integration.

RadNet Executives to Address J.P. Morgan Healthcare Conference

Event summary

  • RadNet executives, including CEO Howard Berger and CFO Mark Stolper, will present at the J.P. Morgan Healthcare Conference on January 14, 2026.
  • The presentation will be webcast live and available for replay at jpmorgan.metameetings.net.
  • RadNet operates 407 outpatient imaging centers across eight states (Arizona, California, Delaware, Florida, Maryland, New Jersey, New York, and Texas).
  • The company's revenue is derived from diagnostic imaging services, radiology IT solutions (DeepHealth), and teleradiology services.

The big picture

RadNet's participation in the J.P. Morgan Healthcare Conference signals an effort to engage with key investors and analysts, particularly as the diagnostic imaging market faces headwinds from reimbursement pressures and technological disruption. The presence of multiple executives, including the CEO, CFO, and Chief Strategy Officer, suggests a focus on communicating a clear strategic vision and addressing investor concerns. The company's scale, with over 400 imaging centers and 11,000 employees, makes it a significant player in the fragmented outpatient imaging market.

What we're watching

Growth Strategy
The conference presentation will likely address RadNet's strategy for expanding its DeepHealth AI solutions and integrating them into existing workflows, a key area for future revenue generation.
Financial Performance
Given the current macroeconomic environment, the market will scrutinize management’s commentary on pricing pressures and cost management initiatives within the diagnostic imaging sector.
Competitive Landscape
The presentation's discussion of market share and competitive dynamics will reveal how RadNet intends to maintain its position as a leading provider amidst increasing competition from larger healthcare systems and specialized imaging centers.

RadNet Bolsters Florida Presence with $100M Radiology Regional Acquisition

Event summary

  • RadNet acquired Radiology Regional, a division of LucidHealth, expanding its presence in Southwest Florida.
  • The acquisition adds 13 imaging centers across five cities (Naples, Cape Coral, Fort Myers, Port Charlotte, and Sarasota) to RadNet's existing five Florida locations.
  • RadNet projects the acquisition will contribute approximately $100 million in revenue in 2026.
  • Radiology Regional employs 400 staff and utilizes 44 contracted radiologists.

The big picture

RadNet's acquisition of Radiology Regional represents a strategic move to capitalize on the growing demand for diagnostic imaging services in Florida, a market driven by demographic trends and an aging population. The $100 million deal underscores the ongoing consolidation within the fragmented outpatient imaging sector, with larger players like RadNet seeking to gain scale and leverage technology to improve efficiency and expand their geographic footprint. LucidHealth's decision to divest Radiology Regional suggests a strategic realignment towards supporting a broader network of radiology practices.

What we're watching

Integration Risk
The success of the acquisition hinges on RadNet's ability to effectively integrate Radiology Regional's operations and technology, a process that can be complex and disruptive.
AI Adoption
The deployment of RadNet’s DeepHealth AI solutions across the acquired centers will be a key indicator of the acquisition’s value proposition and potential for improved clinical outcomes and efficiency.
Market Saturation
Given Florida's aging population and increasing demand for imaging services, RadNet will need to carefully manage capacity and pricing to avoid market saturation and maintain profitability.

RadNet Broadens Executive Roles Amid Imaging and Digital Health Push

Event summary

  • RadNet has promoted four senior leaders to expanded executive roles, effective immediately.
  • Stephen Forthuber and Norman Hames were elevated to CEO roles for Eastern and Western Operations, respectively.
  • Mital Patel assumes the role of Executive Vice President and COO, expanding from Financial Planning and Analysis and Chief Administrative Officer.
  • Greg Sorensen, M.D., transitions from Chief Science Officer to Chief Strategy Officer while retaining a Board of Directors seat.
  • RadNet reports record financial performance across both its Imaging Center and Digital Health segments in recent quarters.

The big picture

RadNet's leadership reshuffle signals an intensified focus on both geographic operational efficiency and a strategic pivot towards preventative healthcare solutions via its DeepHealth brand. The company, with its extensive network of 407 imaging centers and over 11,000 employees, is attempting to capitalize on the growing demand for digital health services and move beyond reactive diagnostics. This expansion of executive roles suggests a desire to accelerate growth and innovation within a competitive market.

What we're watching

Operational Focus
The dual CEO structure for Eastern and Western Operations suggests a potential acknowledgement of regional differences in market dynamics or operational challenges, and whether this structure will enhance agility or create internal silos.
Strategic Direction
Dr. Sorensen’s move to Chief Strategy Officer, coupled with the stated focus on proactive disease prevention, indicates a significant shift in RadNet’s long-term vision, and whether this will require substantial investment in new technologies or partnerships.
Execution Risk
With multiple executive role expansions, the risk of integration challenges and diluted accountability increases, and how effectively RadNet manages these transitions will be critical to sustaining recent financial performance.
CID: 247